B. Tanchel

Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay.

M. Rubin, A. Wyatt, H. Beltran, 2022, NAR cancer.

Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer

C. Gilks, Naveena Singh, K. K. van de Vijver, 2019, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

S. Tavaré, M. Loda, A. Tutt, 2021, Cancer cell.

Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases

I. Ellis, E. Provenzano, S. Pinder, 2021, British Journal of Cancer.

Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results

C. Gilks, T. Bosse, M. Arends, 2019, Histopathology.

Effect of Cavity Shaving on Reoperation Rate Following Breast‐Conserving Surgery

R. Marudanayagam, R. Singhal, B. O’Connor, 2008, The breast journal.

Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma—A Large Multi-Institutional International Study

E. Provenzano, A. Shaaban, C. Galant, 2023, Cancers.

Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland –on behalf of the UK national coordinating committee for breast pathology

E. Provenzano, S. Pinder, E. Rakha, 2023, Breast.

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones

A. Tutt, C. Caldas, E. Provenzano, 2023, Nature communications.